2020 TTF RARE Mutations QA PANEL Why Mutations Have Different Progression-Free Survival Averages

dbrock's picture
Why Different Mutations Have Different Progression-Free Survival Averages
GRACE Videos and Articles
Join us for the 2021 Targeted Therapies Patient Forum, presented Live-Online on July 17, 2021, at 10:00 am eastern time!

 

But meanwhile -- Videos from the 2020 Targeted Therapies Patient Forum are still available! This past event's live-online presentations and discussions were launched by our Event Chair, Luis E. Raez, MD FACP FCCP, Member of the GRACE Board of Directors, President of the Florida Society of Clinical Oncology (FLASCO), and Chief Scientific Officer & Medical Director at Memorial Cancer Institute.

The day-long event featured top oncologists in their field, presenting the most current and emerging information in targeted therapies for patients and caregivers living with lung cancer.

 

In this video from the Rare Mutations session from the event, the panel discusses why different mutations have different progression-free survival averages.

 

We thank our sponsors for their support of this event! #AstraZeneca #Lilly #Novartis #Takeda #FoundationMedicine #BoehringerIngelheim #BlueprintMedicines #Genentech

 

Access to the full agenda can be found here: https://bit.ly/39131em

Full bios for attending faculty can be found here: https://bit.ly/2M0FVLH

To join the conversation, visit https://cancergrace.org/forum.

 

 

Video Language: 

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation